You are here: All Products  > Qilu In-Licenses siRNA Targeting PCSK9 from Ribo in $100 Million Agreement

Qilu In-Licenses siRNA Targeting PCSK9 from Ribo in $100 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.